-
SPAC Target Focus
-
Life Sciences, Healthcare & Medical
-
Expected Close Date
-
April 27, 2023
-
IPO Date
-
2021-10-27
-
IPO Size(M)
-
$ 126M
-
Underwriters
-
Oppenheimer & Co., Lake Street
Management
Barbara L. Weber, M.D., a director nominee, is president and CEO of Tango Therapeutics,
Management Team / Advisory Board Bios
Barbara L. Weber, M.D., a director nominee, is president and CEO of Tango Therapeutics,